Vitreous Zonule and its Relation to Anterior Chamber Angle Characteristics in Primary Angle Closure. 2019

Kilhwan Shon, and Kyung Rim Sung, and Junki Kwon, and Youn Hye Jo
Department of Ophthalmology, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea.

Primary angle-closure (PAC) eyes with no vitreous zonule (VZ) appear to have a narrower angle despite similar lens vault and iris configuration than eyes with visible VZ. To assess the clinical significance of the VZ in PAC. Medical records of 91 eyes of 91 participants with PAC or PAC glaucoma were retrospectively reviewed. Anterior segment parameters were measured using anterior segment optical coherence tomography; presence of the VZ was assessed with ultrasound biomicroscopy. Parameters were compared between eyes with vitreous zonule group (VZG) and no vitreous zonule group (NVZG). Factors associated with VZ presence were determined using logistic regression analysis. The NVZG was more likely to have PAC glaucoma than PAC (51.4% vs. 25.0%; P=0.010) and use more glaucoma medications (0.77 vs. 0.36; P=0.004) than the VZG. The NVZG had a smaller anterior chamber area than the VZG (13.6 mm vs. 15.1 mm; P=0.020) but there were no significant between-group differences in anterior chamber depth (1.97 vs. 2.08 mm; P=0.119) and lens vault (1.21 vs. 1.13 mm; P=0.337). NVZG had a smaller scleral spur angle (11.5 vs. 17.4 degrees; P<0.001), angle opening distance at 500 μm (AOD500, 105 vs. 168 μm; P<0.001), and trabecular-ciliary process angle (75.7 vs. 81.9 degrees; P=0.029) than VZG. Older age [odds ratio (confidence interval), 1.087 (1.014-1.164); P=0.018], less AOD500 (0.984 (0.975-0.993); P<0.001), and less trabecular-ciliary process angle (0.938 (0.901-0.977); P=0.002) were independently associated with an absence of VZ. PAC eyes with no VZ had a narrower angle and required more glaucoma medications than eyes with a VZ.

UI MeSH Term Description Entries
D007429 Intraocular Pressure The pressure of the fluids in the eye. Ocular Tension,Intraocular Pressures,Ocular Tensions,Pressure, Intraocular,Pressures, Intraocular,Tension, Ocular,Tensions, Ocular
D008022 Ligaments Shiny, flexible bands of fibrous tissue connecting together articular extremities of bones. They are pliant, tough, and inextensile. Interosseal Ligament,Interosseous Ligament,Interosseal Ligaments,Interosseous Ligaments,Ligament,Ligament, Interosseal,Ligament, Interosseous
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006068 Gonioscopy Examination of the angle of the anterior chamber of the eye with a specialized optical instrument (gonioscope) or a contact prism lens. Gonioscopies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072776 Slit Lamp Microscopy A procedure that uses a SLIT LAMP to examine structures in the front of the EYE, such as the CONJUNCTIVA; CORNEA; IRIS; and AQUEOUS HUMOR. Slit Lamp Examination,Examination, Slit Lamp,Examinations, Slit Lamp,Microscopy, Slit Lamp,Slit Lamp Examinations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000867 Anterior Chamber The space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. (Cline et al., Dictionary of Visual Science, 4th ed, p109) Anterior Chambers,Chamber, Anterior,Chambers, Anterior
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

Kilhwan Shon, and Kyung Rim Sung, and Junki Kwon, and Youn Hye Jo
January 1986, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
Kilhwan Shon, and Kyung Rim Sung, and Junki Kwon, and Youn Hye Jo
December 2022, Investigative ophthalmology & visual science,
Kilhwan Shon, and Kyung Rim Sung, and Junki Kwon, and Youn Hye Jo
February 2023, Investigative ophthalmology & visual science,
Kilhwan Shon, and Kyung Rim Sung, and Junki Kwon, and Youn Hye Jo
January 2022, Vestnik oftalmologii,
Kilhwan Shon, and Kyung Rim Sung, and Junki Kwon, and Youn Hye Jo
April 1964, The British journal of ophthalmology,
Kilhwan Shon, and Kyung Rim Sung, and Junki Kwon, and Youn Hye Jo
January 1985, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
Kilhwan Shon, and Kyung Rim Sung, and Junki Kwon, and Youn Hye Jo
January 2008, Clinical & experimental ophthalmology,
Kilhwan Shon, and Kyung Rim Sung, and Junki Kwon, and Youn Hye Jo
December 1984, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie,
Copied contents to your clipboard!